Opposition · USPTO

Opposition 91190389

OtherUSPTO

Opposition 91190389 at USPTO between Bayer HealthCare LLC and BioNovix, Inc., over the mark ISONOSTIX, filed May 27, 2009. Status in the office record: other.

Status
Other
Result
Other
Filed
May 27, 2009
Marks involved
16
Parties

Who is involved

The parties as named in the office record.

Opponent

Bayer HealthCare LLC

Respondent

BioNovix, Inc.

Timeline

How the case has moved

Dates from the USPTO record and the ISONOSTIX filing.

  1. ISONOSTIX filed

    Application 77277322 filed at the USPTO.
  2. Opposition filed

    Bayer HealthCare LLC started opposition 91190389 at USPTO against ISONOSTIX.
Marks

Marks involved

1 contested mark, 15 marks the challenger relies on.

MarkRoleApplicationOffice
ISONOSTIXContested77277322USPTO
CLINISTIXRelied on71690988USPTO
HEMASTIXRelied on72021109USPTO
ALBUSTIXRelied on72021497USPTO
URISTIXRelied on72039121USPTO
COMBISTIXRelied on72039123USPTO
DIASTIXRelied on72047810USPTO
LABSTIXRelied on72047811USPTO
HEMA-COMBISTIXRelied on72166881USPTO
AZOSTIXRelied on72201640USPTO
BILI-LABSTIXRelied on72372787USPTO
MULTISTIXRelied on72407137USPTO

+4 more marks in this case

API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

GET /v1/proceedings/{id}
ID=prc_00840354-f8a8-4e97-b110-16e27c747567
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_00840354-f8a8-4e97-b110-16e27c747567",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91190389",
  "status": "other",
  "office_code": "US",
  "filed_date": "2009-05-27",
  "parties": [
    {
      "name": "Bayer HealthCare LLC",
      "role": "opponent"
    },
    {
      "name": "BioNovix, Inc.",
      "role": "respondent"
    }
  ]
}